Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(4-Methoxy-2-nitrophenyl)acetonitrile, with the molecular formula C9H8N2O3, is a yellow crystalline solid that serves as a versatile building block in the realms of organic synthesis and pharmaceutical manufacturing. Characterized by its unique chemical structure and reactivity, (4-METHOXY-2-NITROPHENYL)ACETONITRILE is recognized for its potential as a precursor in the production of an array of drugs and agrochemicals, making it a valuable intermediate in synthesizing a broad spectrum of organic compounds. Its applications extend to chemical research and development, where it is explored for its utility across various industries.

105003-90-5

Post Buying Request

105003-90-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

105003-90-5 Usage

Uses

Used in Organic Synthesis:
(4-Methoxy-2-nitrophenyl)acetonitrile is used as a key intermediate for the synthesis of various organic compounds due to its unique reactivity and chemical structure, facilitating the creation of a wide range of products in the chemical industry.
Used in Pharmaceutical Manufacturing:
In the pharmaceutical sector, (4-Methoxy-2-nitrophenyl)acetonitrile is utilized as a precursor in the production of drugs, contributing to the development of new medications and therapeutic agents.
Used in Agrochemical Production:
(4-METHOXY-2-NITROPHENYL)ACETONITRILE also serves as a precursor in the creation of agrochemicals, playing a role in the development of products designed to enhance agricultural productivity and crop protection.
Used in Chemical Research and Development:
(4-Methoxy-2-nitrophenyl)acetonitrile is employed in research and development initiatives, where its potential applications in different industries are explored and expanded upon, driving innovation and advancement in chemical sciences.

Check Digit Verification of cas no

The CAS Registry Mumber 105003-90-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,0,0 and 3 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 105003-90:
(8*1)+(7*0)+(6*5)+(5*0)+(4*0)+(3*3)+(2*9)+(1*0)=65
65 % 10 = 5
So 105003-90-5 is a valid CAS Registry Number.

105003-90-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(4-Methoxy-2-nitrophenyl)acetonitrile

1.2 Other means of identification

Product number -
Other names 2-(4-methoxy-2-nitrophenyl)acetonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:105003-90-5 SDS

105003-90-5Relevant articles and documents

ETHER COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS

-

, (2017/03/14)

Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I" and I? or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.

Antibodies to aripiprazole haptens and use thereof

-

Page/Page column 42, (2017/05/17)

Disclosed is an antibody which binds to aripiprazole, which can be used to detect aripiprazole in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of aripiprazole, in

Antibodies to Aripiprazole Haptens and Use Thereof

-

Page/Page column, (2014/03/24)

Disclosed is an antibody which binds to aripiprazole, which can be used to detect aripiprazole in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of aripiprazole, in

HAPTENS OF ARIPIPRAZOLE AND THEIR USE IN IMMUNOASSAYS

-

Paragraph 49-50, (2014/03/25)

The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to

2,3-DIHYDRO-1H-INDEN-1-YL-2,7-DIAZASPIRO[3.5] NONANE DERIVATIVES

-

, (2011/10/10)

The present invention provides a compound of Formula (I) or a pharmaceutically salt thereof wherein R1, R2, Ra, L, Z, Z1 and Z2 are as defined herein, that act as Ghrelin antagonists or inverse agonists; pharmaceutical compositions thereof; and methods of treating diseases, disorders, or conditions mediated by the antagonism of the Ghrelin receptor.

TETRAHYDRO-PYRIDOAZEPIN-8-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA

-

, (2010/11/24)

Compounds of formula 1 are disclosed, wherein G, D, A, Q, Y, Z, and R1 through R10 are defined in the specification. Also provided are descriptions of processes for preparing compounds of formula 1, intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.

OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION

-

Page/Page column 18, (2008/06/13)

This invention relates to potent potassium channel blocker compounds of Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relate

OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION

-

Page/Page column 17-18, (2008/06/13)

This invention relates to potent potassium channel blocker compounds of Formula (I) or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also rela

Ophthalmic compositions for treating ocular hypertension

-

, (2008/06/13)

This invention relates to potent potassium channel blocker compounds of Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relate

An aminoisoflavone-salicyloylindole ring transformation

Loewe, Werner,Witzel, Sonja,Tappmeyer, Silvia,Albuschat, Rica

, p. 317 - 326 (2007/10/03)

A series of 2′-nitroisoflavones 8-10, 15, 22, 27 and 28 was prepared via the (2-nitro-phenyl)-acetic acids 1, 13, 19 and 25. In order to obtain the corresponding 2′-aminoisoflavones the reduction of 8-10, 15, 22, 27 and 28 was undertaken. Surprisingly, new 3-salicyloylindoles instead of the expected 2′-aminoisoflavones were the main reduction products. In the following paper the preparation of the 2′-nitroisoflavones 8-10, 15, 22, 27 and 28 as well as the reduction experiments obtaining the 2′-aminoisoflavones 33 and 35 and the 3-salicyloylindoles 29-32, 34 and 36 will be described. Furthermore, a possible mechanism responsible for the formation of the 3-salicyloylindoles from 2′-nitroisoflavones under reductive conditions will be discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 105003-90-5